GeneThera Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
2016
2017
Cash & Short Term Investments
1.40
1.10
1.30
0.10
-
729.90
167.70
Total Accounts Receivable
3.80
5.70
15.00
15.30
22.50
-
-
Total Current Assets
5.20
6.80
16.30
15.40
22.50
-
167.70
Net Property, Plant & Equipment
37.60
46.80
12.80
-
13.00
-
26.40
Total Investments and Advances
-
-
-
-
110.60
-
-
Other Assets
7.00
7.00
7.00
-
-
-
12
Total Assets
49.80
60.60
36.10
15.40
146.10
-
206.10
ST Debt & Current Portion LT Debt
952.60
1,538.80
906.00
962.00
1,933.70
Accounts Payable
656.70
1,035.40
1,505.80
1,517.00
-
Other Current Liabilities
1,458.40
2,051.10
2,906.80
3,275.30
4,736.40
Total Current Liabilities
3,067.80
4,625.30
5,318.60
5,754.30
6,670.10
Total Liabilities
3,067.80
4,625.30
5,318.60
5,754.30
6,670.10
Common Equity (Total)
3,050.70
4,577.10
5,297.90
5,754.30
6,539.40
Total Shareholders' Equity
3,035.30
4,561.70
5,282.50
5,738.80
6,524.00
Total Equity
3,018.00
4,564.80
5,282.50
5,738.80
6,524.00
Liabilities & Shareholders' Equity
49.80
60.60
36.10
15.40
146.10
Accumulated Minority Interest
17.30
3.10
-
-
-
Preferred Stock (Carrying Value)
15.40
15.40
15.40
15.40
15.40

About GeneThera

View Profile
Address
6860 Broadway
Denver Colorado 80221
United States
Employees -
Website http://www.genethera.net
Updated 07/08/2019
GeneThera, Inc. is a biotechnology company. The company is focused on improving food safety by applying the molecular technologies to eradicate zoonotic diseases, such as Johne's, Mad Cow, Chronic Wasting, and E. coli disease.